Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DRMA...............................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
DRMA.................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
DRMA: And when all is said & done, a classic TOILET FLUSH!!! (Heck with this shit, I'm goin' back to Vegas!!)
Yep I'm well. Same to you as well.
Gonna try to jump in here in the AM if it don't get too far gone.
Thank you, buddy! Hope you're doing well and happy new year!
Absolutely, nice move here.
Win or loose I had to take a shot. You know me well lol
NICE BUYS, BETTER LATE THAN NEVER
Zorro just filled at $1.12 now gonna sleep on it lol
Nothing makes sense anymore! Most of the Pink Sheets have no liquidity anymore. This BS on the NASDAQ is the only game of chance lol
I'm jumping in now
Must be time to buy:
https://www.barchart.com/stocks/quotes/DRMA/opinion
GOOD ALERT ON NEWS, THE CHART IS A PRIME EXAMPLE OF HOW CRAZY THIS MARKET REALLY IS
https://finviz.com/quote.ashx?t=DRMA&ty=c&ta=1&p=d
Lol! Scared money doesn't make any. Sometimes you just have to go with your instincts.
DRMAW (Warrants): Closed UP by 153% today in the OPEN Market --- before the Post-M news even hit (Insiders at work).
I have to think a good chunk of that 7 million offering got bought. I'm thinking about taking a slice on a dip because IMHO this could fly past $2.00 tomorrow. Total game of craps but I'm a compulsive gambler :)
Always the guess with AH. Dang MM like to play early PM.
This baby is flying to new heights! Will be interesting how she does tomorrow
Made some nice money on the warrants if they sold.
Thanks! At what price if you know. OVER 7m just traded.
I used to trade this one. Haven't seen it in a while. There is an offering for 7.1 million shares
Was wondering why it was moving. Low floater 3.54M worth keeping an eye on.. Thanks for posting.
NEWS
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
- This is the Company's first patent issued for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -
- The Company is currently discussing partnership opportunities to advance development of DMT410 -
- In 2022, the Japanese prevalence of hyperhidrosis was 10%, with approximately 6% having primary axillary hyperhidrosis -
SAN DIEGO, CA / ACCESSWIRE / January 4, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Japanese Patent No. 7395576) further strengthens Dermata's intellectual property for DMT410 for the treatment of hyperhidrosis and could lead to further protections for additional indications.
"We believe this patent issuance further validates DMT410's novel concept to easily deliver botulinum toxin topically instead of requiring patients to receive multiple injections," says Gerry Proehl, Dermata's Chairman, President, and CEO. "We are excited about the opportunities the DMT410 program can bring to patients, not only for the treatment of axillary hyperhidrosis as we have seen in our proof-of-concept study, but potentially for palmer and plantar hyperhidrosis which has no currently approved products. We also believe there are opportunities to use DMT410 to treat many aesthetic skin conditions like reducing pore number and size, decreasing sebum production, and reducing fine lines and wrinkles, all while improving the look and quality of facial skin," continued Mr. Proehl. "We also believe this new patent could aid us in our partnership discussions with a company that has a botulinum toxin to further develop the DMT410 program for multiple indications."
About DMT410
Gap filled from this mornings opening and may be consolidating now.
DRMA................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783
$DRMA low floater 2.9 mil, heavily oversold, might have to start buying a few of this one.
$drma Recent DRMA News
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:18:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:30 PM
$drma
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:31:21 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/28/2023 04:15:22 AM
$DRMA Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/27/2023 08:50:42 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/07/2023 08:21:18 PM
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
230
|
Created
|
08/30/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |